Skip to content

Prospective study on health improvement of relocated from very high altitude to lower altitude resident

Prospective study on health improvement of relocated from very high altitude to lower altitude resident

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047945
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-06-24
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high altitude disease

Interventions

case series:relocation

Sponsors

People's Hospital of Tibet Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 7 years, strive for 50% male and 50% female; 2. Living at extra high altitude for generations (altitude >= 4500 meters); 3. Those who voluntarily signed the informed consent to participate in this study (Note: Subjects without independent decision-making ability will be decided by their guardians whether to participate in this study).

Exclusion criteria

Exclusion criteria: 1. Participate in the researcher for more than 7 days and live at an altitude of 200 mmHg, diastolic blood pressure > 100 mmHg); 7. Bradycardia, severe arrhythmia; patients with aortic aneurysm; 8. Severe hyperthyroidism; 9. Various situations that cannot be understood and cannot actively cooperate with the inspection, such as disturbance of consciousness or intellectual disability; 10. Heart rate > 120 beats/min or SPO2 < 90%; pneumothorax, giant lung cannon and not ready for surgery; 11. Patients with tympanic membrane perforation (the patient's ear canal needs to be blocked first and then measured); 12. Patients with recent respiratory tract infection (<4 weeks); patients with acute infectious diseases; 13. Patients with low immunity; people with weak body; 14. Because of other conditions that may aggravate the condition by blowing too hard.

Design outcomes

Secondary

MeasureTime frame
Blood routine;Renal and liver function;Electrolyte;Brain natriuretic;C reactive protein;Blood lipids;

Primary

MeasureTime frame
Echocardiography;Pulmonary function;Cerebral oxygen saturation;

Countries

China

Contacts

Public ContactGesang Luobu

People's Hospital of Tibet Autonomous Region

Gesang5353@sina.com+86 13549010066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026